Deva Holding AS | 销售和管理费用

金融业

TRY

TRY 12.93B

现金及等价物

TRY 775.92M

TRY 991.13M

TRY 9.13B

TRY 6.43B

TRY 5.3B

股息收益率

0.18

TRY 820.88M

TRY 882.9M

EPS每股收益

TRY 2.92

股本和储备

TRY 5.79B

TRY 1.32B

债务利息支出

TRY 272.53M

TRY 559.97M

TRY 14.89B

TRY 583.98M

TRY 1.35B

TRY 964.87M

普通股股本

TRY 200.02M

6.55

TRY 2.32B

销售和管理费用

TRY 462.26M

贸易债权人

TRY 809.81M

应收帐款人

TRY 3.03B

	销售和管理费用	更改		日
Akebia Therapeutics	USD 25.74M		1.93M	2025-03
Alaunos Therapeutics	USD 585K		260K	2025-09
Avita Medical	AUD 20.98M		253K	2025-06
Deva Holding AS	TRY 462.26M		48.18M	2023-09
Dianthus Therapeutics	USD 8.2M		669K	2025-09
Ionis Pharmaceuticals	USD 86.56M		4.04M	2025-09
IQVIA Holdings	USD 468M		46M	2025-12
Moderna	USD 308M		40M	2025-12
Organon & Co	USD 399M		54M	2025-09
Revvity	USD 251.73M		9.82M	2025-12
Tectonic Therapeutic	USD 4.96M		190K	2025-09
Viatris	USD 886.6M		42.1M	2025-09
Xeris Pharmaceuticals	USD 46.46M		2.07M	2025-09

Deva Holding AS 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.